How the cornea heals: Cornea-specific repair mechanisms affecting surgical outcomes

Cornea

Volumn 24, Issue 8 SUPPL., 2005, Pages

  Fini, M Elizabeth ^a   Stramer, Brian M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Epithelial mesenchymal interaction; Fibrosis; Matrix metalloproteinase; TGF ; Wound healing

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA SMOOTH MUSCLE ACTIN; ALPHA5 INTEGRIN; COLLAGENASE; CRYSTALLIN; FIBRIN; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEASOME; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSKETOLASE; UBIQUITIN;

CONFERENCE PAPER; CONTRACTURE; CORNEA CELL; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA SURGERY; DEBRIDEMENT; FIBROSIS; HUMAN; KERATOMILEUSIS; MESENCHYME; NONHUMAN; PENETRATING TRAUMA; PHOTOREFRACTIVE KERATECTOMY; PRIORITY JOURNAL; REFRACTION ERROR; SCAR FORMATION; SURGICAL TECHNIQUE; TISSUE REGENERATION; TREATMENT OUTCOME; UBIQUITINATION; WOUND HEALING;

EID: 28044450903     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000178743.06340.2c     Document Type: Conference Paper

References (142)

1. Desmouliere A, Gabbiani G. The role of the myofibroblast in wound healing and fibrocontractive diseases. In: Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1996: 391-423.
2. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol. 1994;124:401-404.
3. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res. 1999;18:529-551.
4. Beales MP, Funderburgh JL, Jester JV, et al. Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest Ophthalmol Vis Sci. 1999;40: 1658-1663.
5. Martin P. Wound healing-aiming for perfect skin regeneration. Science. 1997;276:75-81.
6. Stocum DL. Amphibian regeneration and stem cells. Curr Top Microbiol Immunol. 2004;280:1-70.
7. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004;5:836-847.
8. Bisgaard HC, Thorgeirsson SS. Hepatic regeneration. The role of regeneration in pathogenesis of chronic liver diseases. Clin Lab Med. 1996;16:325-339.
9. Min AD, Theise ND. Prospects for cell-based therapies for liver disease. Panminerva Med. 2004;46:43-48.
10. Ramadori G, Saile B. Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology. 2004;127:997-1000.
11. Ferguson MW, O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci. 2004;359:839-850.
12. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci. 1995;108:985-1002.
13. Moller-Pedersen T, Cavanagh HD, Petroll WM, et al. Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK. Curr Eye Res. 1998;17:736-747.
14. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999; 341:738-746.
15. Meek KM, Fullwood NJ. Corneal and scleral collagens-a microscopist's perspective. Micron. 2001;32:261-272.
16. Meek KM, Boote C. The organization of collagen in the corneal stroma. Exp Eye Res. 2004;78:503-512.
17. Marchant JK, Hahn RA, Linsenmayer TF, et al. Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphology. J Cell Biol. 1996;135:1415-1426.
18. Birk DE. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron. 2001;32:223-237.
19. Funderburgh JL, Corpuz LM, Roth MR, et al. Mimecan, the 25-kDa corneal keratan sulfate proteoglycan, is a product of the gene producing osteoglycin. J Biol Chem. 1997;272:28089-28095.
20. Dunlevy JR, Beales MP, Berryhill BL, et al. Expression of the keratan sulfate proteoglycans lumican, keratocan and osteoglycin/mimecan during chick corneal development. Exp Eye Res. 2000;70:349-362.
21. Chakravarti S. Functions of lumican and fibromodulin: lessons from knockout mice. Glycoconj J. 2002;19:287-293.
22. Funderburgh JL. Keratan sulfate: structure, biosynthesis, and function. Glycobiology. 2000;10:951-958.
23. Kao WW, Liu CY. Roles of lumican and keratocan on corneal transparency. Glycoconj J. 2002;19:275-285.
24. Davison PF, Galbavy EJ. Connective tissue remodeling in corneal and scleral wounds. Invest Ophthalmol Vis Sci. 1986;27:1478-1484.
25. Binder PS. Radial keratotomy and excimer laser photorefractive keratectomy for the correction of myopia. J Refract Corneal Surg. 1994; 10:443-464.
26. Grosvenor T. How predictable are the results of excimer laser photorefractive keratectomy? A review. Optom Vis Sci. 1995;72:698-712.
27. Wilson SE, Kim WJ. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci. 1998;39:220-226.
28. Streilein JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol. 1997;158:3557-3560.
29. Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998;290:S12-S23.
30. Clark RA. Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. J Invest Dermatol. 1990;94:128S-134S.
31. Fujikawa LS, Foster CS, Harrist TJ, et al. Fibronectin in healing rabbit corneal wounds. Lab Invest. 1981;45:120-129.
32. Clark RA. Biology of dermal wound repair. Dermatol Clin. 1993;11: 647-666.
33. Weimar V. Healing processes in the cornea. In: Duke-Elder S, Perkins ES, eds. The Transparency of the Cornea. Oxford: Blackwell Scientific Publications, 1960;111.
34. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999;18:293-309.
35. Wilson SE, Mohan RR, Ambrosio R Jr, et al. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 2001;20:625-637.
36. Imanishi J, Kamiyama K, Iguchi I, et al. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19:113-129.
37. Li DQ, Lee SB, Tseng SC. Differential expression and regulation of TGF-beta1, TGF-beta2, TGF-beta3, TGF-betaRI, TGF-betaRII and TGF-betaRIII in cultured human corneal, limbal, and conjunctival fibroblasts. Curr Eye Res. 1999;19:154-161.
38. Jester JV, Moller-Pedersen T, Huang J, et al. The cellular basis of corneal transparency: evidence for 'corneal crystalline'. J Cell Sci. 1999;112: 613-622.
39. Piatigorsky J. Review: a case for corneal crystalline. J Ocul Pharmacol Ther. 2000;16:173-180.
40. Piatigorsky J. Enigma of the abundant water-soluble cytoplasmic proteins of the cornea: the "refraction" hypothesis. Cornea. 2001;20: 853-858.
41. Desmouliere A, Geinoz A, Gabbiani F, et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122:103-111.
42. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005;13:7-12.
43. Ronnov-Jessen L, Petersen OW. A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts. J Cell Blol. 1996;134:67-80.
44. Jester JV, Petroll WM, Barry PA, et al. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci. 1995;36:809-819.
45. Stramer BM, Zieske JD, Jung JC, et al. Molecular mechanisms controlling the fibrotic repair phenotype in cornea: implications for surgical outcomes. Invest Ophthalmol Vis Sci. 2003;44:4237-4246.
46. Tomasek JJ, Gabbiani G, Hinz B, et al. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349-363.
47. Moller-Pedersen T, Li HF, Petroll WM, et al. Confocal microscopic characterization of wound repair after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 1998;39:487-501.
48. Moller-Pedersen T, Cavanagh HD, Petroll WM, et al. Stromal wound healing explains refractive instability and haze development after photorefractive keratectomy: a 1-year confocal microscopic study. Ophthalmology. 2000;107:1235-1245.
49. Cintron C, Schneider H, Kublin C. Corneal scar formation. Exp Eye Res. 1973;17:251-259.
50. Cintron C, Kublin CL. Regeneration of corneal tissue. Dev Biol. 1977; 61:346-357.
51. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res. 1999; 18:311-356.
52. Moller-Pedersen T. Keratocyte reflectivity and corneal haze. Exp Eye Res. 2004;78:553-560.
53. Ivarsen A, Laurberg T, Moller-Pedersen T. Characterisation of corneal fibrotic wound repair at the LASIK flap margin. Br J Ophthalmol. 2003; 87:1272-1278.
54. Girard MT, Matsubara M, Kublin C, et al. Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling. J Cell Sci. 1993;104:1001-1011.
55. Jester JV, Barry-Lane PA, Cavanagh HD, et al. Induction of alpha- smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996;15:505-516.
56. Cook JR, Mody MK, Fini ME. Failure to activate transcription factor NF-kappaB in corneal stromal cells (keratocytes). Invest Ophthalmol Vis Sci. 1999;40:3122-3131.
57. West-Mays JA, Strissel KJ, Sadow PM, et al. Competence for collagenase gene expression by tissue fibroblasts requires activation of an interleukin 1 alpha autocrine loop. Proc Natl Acad Sci U S A. 1995; 92:6768-6772.
58. Fini ME, Strissel KJ, Girard MT, et al. Interleukin 1 alpha mediates collagenase synthesis stimulated by phorbol 12-myristate 13-acetate. J Biol Chem. 1994;269:11291-11298.
59. Stramer BM, Fini ME. Uncoupling keratocyte loss of corneal crystallin from markers of fibrotic repair. Invest Ophthalmol Vis Sci. 2004;45: 4010-4015.
60. Jester JV, Huang J, Barry-Lane PA, et al. Transforming growth factor beta-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest Ophthalmol Vis Sci. 1999;40: 1959-1967.
61. Masur SK, Dewal HS, Dinh TT, et al. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci U S A. 1996; 93:4219-4223.
62. Jester JV, Barry-Lane PA, Petroll WM, et al. Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit. Cornea. 1997;16:177-187.
63. Maltseva O, Folger P, Zekaria D, et al. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest Ophthalmol Vis Sci. 2001;42:2490-2495.
64. Zieske JD, Guimaraes SR, Hutcheon AE. Kinetics of keratocyte proliferation in response to epithelial debridement. Exp Eye Res. 2001; 72:33-39.
65. Mohan R, Chintala SK, Jung JC, et al. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem. 2002;277:2065-2072.
66. Miyamoto T, Saika S, Yamanaka A, et al. Wound healing in rabbit corneas after photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg. 2003;29:153-158.
67. Nakamura K. Interaction between injured corneal epithelial cells and stromal cells. Cornea. 2003;22:S35-S47.
68. Nakamura K, Kurosaka D, Bissen-Miyajima H, et al. Intact corneal epithelium is essential for the prevention of stromal haze after laser assisted in situ keratomileusis. Br J Ophthalmol. 2001;85:209-213.
69. O'Kane S, Ferguson MW. Transforming growth factor betas and wound healing. Int J Biochem Cell Biol. 1997;29:63-78.
70. Saika S. TGF-beta signal transduction in corneal wound healing as a therapeutic target. Cornea. 2004;23:S25-S30.
71. Saika S, Liu CY, Azhar M, et al. TGFbeta2 in corneal morphogenesis during mouse embryonic development. Dev Biol. 2001;240:419-432.
72. Nishida K, Sotozono C, Adachi W, et al. Transforming growth factor-beta 1, -beta 2 and -beta 3 mRNA expression in human cornea. Curr Eye Res. 1995;14:235-241.
73. Strissel KJ, Rinehart WB, Fini ME. A corneal epithelial inhibitor of stromal cell collagenase synthesis identified as TGF-beta 2. Invest Ophthalmol Vis Sci. 1995;36:151-162.
74. Strissel KJ, Rinehart WB, Fini ME. Regulation of paracrine cytokine balance controlling collagenase synthesis by corneal cells. Invest Ophthalmol Vis Sci. 1997;38:546-552.
75. Nakamura K, Kurosaka D, Yoshino M, et al. Injured corneal epithelial cells promote myodifferentiation of corneal fibroblasts. Invest Ophthalmol Vis Sci. 2002;43:2603-2608.
76. Nishida K, Kinoshita S, Yokoi N, et al. Immunohistochemical localization of transforming growth factor-beta 1, -beta 2, and -beta 3 latency-associated peptide in human cornea. Invest Ophthalmol Vis Sci. 1994;35:3289-3294.
77. Holgate ST, Davies DE, Lackie PM, et al. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol. 2000;105:193-204.
78. Knight D. Epithelium-fibroblast interactions in response to airway inflammation. Immunol Cell Biol. 2001;79:160-164.
79. Mio T, Liu XD, Adachi Y, et al. Human bronchial epithelial cells modulate collagen gel contraction by fibroblasts. Am J Physiol. 1998; 274:L119-L126.
80. Zhang S, Smartt H, Holgate ST, et al. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. Lab Invest. 1999;79: 395-405.
81. Sacco O, Romberger D, Rizzino A, et al. Spontaneous production of transforming growth factor-beta 2 by primary cultures of bronchial epithelial cells. Effects on cell behavior in vitro. J Clin Invest. 1992;90: 1379-1385.
82. Gizycki MJ, Adelroth E, Rogers AV, et al. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol. 1997;16:664-673.
83. Altraja A, Laitinen A, Virtanen I, et al. Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. Am J Respir Cell Mol Biol. 1996;15:482-488.
84. Laitinen A, Altraja A, Kampe M, et al. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med. 1997;156:951-958.
85. Andriessen MP, Niessen FB, Van de Kerkhof PC, et al. Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study. J Pathol. 1998;186:192-200.
86. Machesney M, Tidman N, Waseem A, et al. Activated keratinocytes in the epidermis of hypertrophic scars. Am J Pathol. 1998;152:1133-1141.
87. Levine JH, Moses HL, Gold LI, et al. Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair. Am J Pathol. 1993;143:368-380.
88. Frank S, Madlener M, Werner S. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem. 1996;271:10188-10193.
89. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol. 2000;1:169-178.
90. Piek E, Ju WJ, Heyer J, et al. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem. 2001;276:19945-19953.
91. Nomura M, Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature. 1998;393:786-790.
92. Weinstein M, Yang X, Li C, et al. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor Smad2. Proc Natl Acad Sci U S A. 1998;95:9378-9383.
93. Datto MB, Frederick JP, Pan L, et al. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol. 1999;19:2495-2504.
94. Ashcroft GS, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol. 1999;1:260-266.
95. Cogan JG, Subramanian SV, Polikandriotis JA, et al. Vascular smooth muscle alpha-actin gene transcription during myofibroblast differentiation requires Sp1/3 protein binding proximal to the MCAT enhancer. J Biol Chem. 2002;277:36433-36442.
96. Hu B, Wu Z, Phan SH. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am J Respir Cell Mol Biol. 2003;29:397-404.
97. Saika S, Kono-Saika S, Ohnishi Y, et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol. 2004;164:651-663.
98. Saika S, Kono-Saika S, Tanaka T, et al. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest. 2004;84:1245-1258.
99. Muragaki Y, Shiota C, Inoue M, et al. Alpha 1 (VIII)-collagen gene transcripts encode a short chain collagen polypeptide and are expressed by various epithelial, endothelial and mesenchymal cells in a new born mouse tissues. Eur J Biochem. 1992;207:895-902.
100. Zhao S, Overbeek PA. Elevated TGFbeta signaling inhibits ocular vascular development. Dev Biol. 2001;237:45-53.
101. Stramer BM, Austin JS, Roberts AB, et al. Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3. J Cell Physiol. 2005;203:226-232.
102. Zhao J, Shi W, Wang YL, et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol. 2002;282:L585-L593.
103. Hocevar BA, Brown TL, Howe PH. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 1999;18:1345-1356.
104. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem. 2001;276:17058-17062.
105. Flanders KC, Major CD, Arabshahi A, et al. Interference with transforming growth factor-beta/Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am J Pathol. 2003;163: 2247-2257.
106. Zieske JD, Mason VS, Wasson ME, et al. Basement membrane assembly and differentiation of cultured corneal cells: importance of culture environment and endothelial cell interaction. Exp Cell Res. 1994;214: 621-633.
107. Pallikaris IG, Karoutis AD, Lydataki SE, et al. Rotating brush for fast removal of corneal epithelium. J Refract Corneal Surg. 1994;10:439-442.
108. Chen CC, Chang JH, Lee JB, et al. Human corneal epithelial cell viability and morphology after dilute alcohol exposure. Invest Ophthalmol Vis Sci. 2002;43:2593-2602.
109. Shimazaki J, Yang H-Y, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical burns. Ophthalmology. 1997;104:2068-2076.
110. Strissel K, Rinehart W, Fini M. Regulation of paracrine cytokine balance controlling collagenase synthesis by corneal cells. Invest Ophthalmol Vis Sci. 1997;38:546-552.
111. Cintron C, Hassinger LC, Kublin CL, et al. Biochemical and ultrastructural changes in collagen during corneal wound healing. J Ultrastruct Res. 1978;65:13-22.
112. Cionni RJ, Katakami C, Lavrich JB, et al. Collagen metabolism following corneal laceration in rabbits. Curr Eye Res. 1986;5:549-558.
113. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol. 2002;3:207-214.
114. Fini ME, Girard MT. The pattern of metalloproteinase expression by corneal fibroblasts is altered by passage in cell culture. J Cell Sci. 1990; 97:373-383.
115. Matsubara M, Girard MT, Kublin CL, et al. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev Biol. 1991;147:425-439.
116. Matsubara M, Zieske J, Fini M. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci. 1991;32:3221-3237.
117. Fini ME, Yue BY, Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas. Curr Eye Res. 1992;11:849-862.
118. Fini ME, Girard MT. Non-coordinate regulation of metalloproteinase gene expression in cornea. Matrix Suppl. 1992;1:203-204.
119. Ando H, Twining S, Yue B, et al. MMPs and proteinase inhibitors in the human aqueous humor. Invest Ophthalmol Vis Sci. 1993;34:3541-3548.
120. Brown D, Chwa M, Escobar M, et al. Characterization of the major matrix degrading metalloproteinase of human corneal stroma. Evidence for an enzyme/inhibitor complex. Exp Eye Res. 1991;52:5-16.
121. Johnson-Muller B, Gross J. Regulation of corneal collagenase production: epithelial-stromal cell interactions. Proc Natl Acad Sci U S A. 1978;75:4417-4421.
122. Johnson-Wint B. Regulation of stromal cell collagenase production in adult rabbit cornea: in vitro stimulation and inhibition by epithelial cell products. Proc Natl Acad Sci U S A. 1980;77:5331-5335.
123. Wilson SE, Schultz GS, Chegini N, et al. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res. 1994;59:63-71.
124. Adamis AP, Meklir B, Joyce NC. In situ injury-induced release of basic-fibroblast growth factor from corneal epithelial cells. Am J Pathol. 1991; 139:961-967.
125. Folkman J, Klagsbrun M, Sasse J, et al. A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. Am J Pathol. 1988;130:393-400.
126. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463-516.
127. Werb Z, Chin JR. Extracellular matrix remodeling during morphogenesis. Ann N Y Acad Sci. 1998;857:110-118.
128. Lukashev ME, Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol. 1998;8:437-441.
129. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 1997;91:439-442.
130. Damsky CH, Werb Z. Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol. 1992;4:772-781.
131. Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol. 1989;1:974-982.
132. Girard MT, Matsubara M, Fini ME. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci. 1991;32:2441-2454.
133. West-Mays JA, Sadow PM, Tobin TW, et al. Repair phenotype in corneal fibroblasts is controlled by an interleukin-1 alpha autocrine feedback loop. Invest Ophthalmol Vis Sci. 1997;38:1367-1379.
134. Kheradmand F, Werner E, Tremble P, et al. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science. 1998;280:898-902.
135. Hoff H, Zhang H, Sell C. Protein degradation via the proteosome. Methods Mol Biol. 2004;285:79-92.
136. Stramer BM, Cook JR, Fini ME, et al. Induction of the ubiquitin-proteasome pathway during the keratocyte transition to the repair fibroblast phenotype. Invest Ophthalmol Vis Sci. 2001;42:1698-1706.
137. Jester JV. Refractive surgical wound healing mechanisms revisited: a glimpse at the future of LASEK. (In press)
138. Pilling D, Buckley CD, Salmon M, et al. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol. 2003;171:5537-5546.
139. Kataoka K, Medina RJ, Kageyama T, et al. Participation of adult mouse bone marrow cells in reconstitution of skin. Am J Pathol. 2003;163: 1227-1231.
140. Korbling M, Estrov Z. Adult stem cells for tissue repair-a new therapeutic concept? N Engl J Med. 2003;349:570-582.
141. Hennessy B, Korbling M, Estrov Z. Circulating stem cells and tissue repair. Panminerva Med. 2004;46:1-11.
142. Nakamura T, Ishikawa F, Sonoda KH, et al. Characterization and distribution of bone marrow-derived cells in mouse cornea. Invest Ophthalmol Vis Sci. 2005;46:497-503.